UK/EU Industry ‘Still Working In The Dark’ On Post-Brexit Regulation
Manufacturing & Northern Ireland The Most Taxing Issues
Executive Summary
As the final scheduled round of post-Brexit trade talks begins amid growing concern over the prospect of a deal and the pervasive threat of COVID-19, pharmaceutical industry bodies in the UK and the EU have issued an urgent call for an MRA on medicines GMP. They also want to see a one-year phase-in of medicines-related aspects of the Northern Ireland Protocol.